FDA Inspection 743660 — Glenmark Pharmaceuticals Inc., USA

Glenmark Pharmaceuticals Inc., USA — FEI 3005658103

The FDA completed an inspection of Glenmark Pharmaceuticals Inc., USA on Sep 9, 2011 in Elmwood Park, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Sep 9, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Elmwood Park, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.